Health

May need ‘disruptive’ regulations to fight opioid epidemic

Gottlieb said the agency is usually having discussions with drug companies about the brand new packaging solutions. “Something like in which could move potentially quickly,” he said. “We’re invested in taking a hard look at in which as well as seeing what the opportunities are.” Opioids, including prescription painkillers as well as heroin, played a role in more than 33,000 ...

Read More »

Amazon pharmaceutical move: acquisition targets

Dr. Mark Frisse, Department of Biomedical Informatics at Vanderbilt University Medical Center along with former chief medical officer at Express Scripts. What is usually the item? Express Scripts is usually the largest pharmacy benefits manager inside United States. These companies, known as PBMs, act as intermediaries between payers, like health insurers, along with the rest of the health system. Why? ...

Read More »

Teva plunges 18% after drugmaker lowers 2017 outlook again

Teva Pharmaceutical Industries, the entire world’s biggest generic medicine maker, warned on 2017 earnings on Thursday after reporting a fall in third-quarter profit hurt by competition inside the U.S. market. Shares plunged nearly 18 percent on Thursday morning. A day earlier U.S. shareholder Allergan announced the idea could begin selling down its 10 percent stake inside the Israeli company, whose ...

Read More »

Envision tanks after earnings miss, will review strategic alternatives

Envision Healthcare shares tanked 34.2 percent to a 52-week low after the company posted a weaker-than-expected profit. The S&P 500, meanwhile, rose 0.1 percent as well as also hit an all-time high. On Tuesday, the company reported adjusted earnings per share of 73 cents for the third quarter, well below the Reuters estimate of 88 cents. Envision’s revenue of $1.99 ...

Read More »

Pharma CEOs welcome Amazon to disrupt drug distribution

The prospect of which Amazon will enter the pharmacy space has cast a pall over stocks of drug distributors along with retail pharmacies, erasing hundreds of millions of dollars coming from their market value. yet in another sector of the drug space, Amazon’s entry could be welcomed: pharmaceutical companies. “Just like science can be disrupted with gene therapy or novel ...

Read More »

‘the idea wasn’t desperation, the idea was tenacity’

Allergan’s controversial deal with the Saint Regis Mohawk tribe giving the group the patent rights to one of its key drugs was widely misunderstood, Allergan CEO Brent Saunders told CNBC. “I think there’s a lot of misunderstanding on why we did the idea,” Saunders told “Mad Money” host Jim Cramer in a Wednesday interview. “the idea wasn’t desperation, the idea ...

Read More »

Why Wall Street has suddenly turned positive on Kellogg

The consumer packaged goods space has been notoriously difficult, so CNBC’s Jim Cramer wasn’t all that will surprised when he saw mass analyst upgrades within the stock of Kellogg. “They’ve got to like something, don’t they?” the “Mad Money” host quipped. “that will might as well be Special K, down nearly 15 percent for the year that has a brand-new ...

Read More »

brand-new Jersey sues OxyContin maker, claims the idea misled public

brand-new Jersey filed a lawsuit Tuesday against the company of which manufactures OxyContin, claiming a “direct link” between the state’s opioid crisis in addition to also the firm’s deceptive marketing practices. State Attorney General Christopher Porrino says the a few-count lawsuit against Connecticut-based Purdue Pharma in addition to also two of its entities seeks undisclosed monetary damages for fraud in ...

Read More »

global trend undermines economies, Novo Nordisk CFO says

An inexorable global rise in diabetes must be taken “more seriously” by society, according to the chief financial officer at the entire world’s top a new of diabetes drugs. “Our view will be in which we have got to make This kind of transparent in which This kind of will be an avalanche of obesity along with diabetes which will ...

Read More »

Fatty liver disease affects 80 million Americans

As American waistlines continue to expand, a lesser-known obesity-related disease is usually quickly becoming more common. In fact, in its most serious form, the disease is usually estimated to become the leading cause for liver transplants by 2020, outpacing even hepatitis C. that will’s known as nonalcoholic fatty liver disease (NAFLD), an umbrella term for a range of liver conditions ...

Read More »